Factors influencing time between surgery and radiotherapy: A population based study of breast cancer patients

S. Katik, M. Gort, J.J. Jobsen, J.H. Maduro, H. Struikmans, S. Siesling*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

1 Citation (Scopus)
2 Downloads (Pure)

Abstract

This study describes variation in the time interval between surgery and radiotherapy in breast cancer (BC) patients and assesses factors at patient, hospital and radiotherapy centre (RTC) level influencing this variation. To do so, the factors were investigated in BC patients using multilevel logistic regression. The study sample consisted of 15,961 patients from the Netherlands Cancer Registry at 79 hospitals and 19 (RTCs) with breast-conserving surgery or mastectomy directly followed by radiotherapy. The percentage of patients starting radiotherapy ≤42 days varied from 14% to 94%. Early year of incidence, higher age, higher stage, mastectomy, higher ASA category and no availability of radiotherapy facilities were significantly associated with a longer time interval between radiotherapy and surgery. More patients received radiotherapy ≤42 days in hospitals with on-site radiotherapy facilities (OR 1.36, p = 0.024). Among the remainder, significant variation was found at the RTC level (11.1%, σ2 = 0.254, SE 0.054), and at the hospital level (6.4% σ2 = 0.443, SE 0.163) (ICC 0.064). The significant delay and unexplained variance remaining at the RCT and hospital level suggests delays caused by the patient referral pathway from hospital to RCT, and indicates potential for improvement at both levels.

Original languageEnglish
Pages (from-to)468-475
Number of pages8
JournalThe Breast
Volume24
Issue number4
DOIs
Publication statusPublished - 1 Aug 2015

Keywords

  • Breast cancer
  • Practice guidelines
  • Quality of care
  • Radiotherapy
  • Timelines

Fingerprint

Dive into the research topics of 'Factors influencing time between surgery and radiotherapy: A population based study of breast cancer patients'. Together they form a unique fingerprint.

Cite this